Asprant Life Science Private Limited, a active private limited company, was established on 24 May 2018 in Kolkata, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24299WB2018PTC226270. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.16 M.
Employing 10 professional, Its leadership includes Sutapa Chakraborty (Director), Raju Talukdar (Director), Suvam Chakraborty (Additional Director). Past directors included Sutapa Chakraborty, Raju Talukdar, Suvam Chakraborty. It holds ₹2.00 M open charges and ₹2.00 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A/53, Purbadiganta,, Kolkata, West Bengal, 700075.
U24299WB2018PTC226270
226270
24 May 2018
₹1.00 M
₹0.16 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Asprant Life Science Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sutapa Chakraborty | Director | 01 Dec 2018 | Current |
| Raju Talukdar | Director | 15 Dec 2022 | Current |
| Suvam Chakraborty | Additional Director | 29 Nov 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 06 Nov 2019 | Past |
| Pramod Abcsdd | Additional Director | 13 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 13 Sep 2023 | Past |
| Pramod Abcsdd | Director | 31 Dec 2018 | Past |
| Pramod Abcsdd | Director | 29 Jan 2022 | Past |
| Pramod Abcsdd | Additional Director | 01 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Asprant Life Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.43% decrease. The company also saw a substantial fall in profitability, with a 306.24% decrease in profit. The company's net worth observed a substantial decline by a decrease of 49.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Asprant Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹2,000,000.00
₹2,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Feb 2024 | Others | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Asprant Life Science has a workforce of 10 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Asprant Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asprant Life Science's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Asprant Life Science Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
A charge registered on 17 Feb 2024 via Charge ID 100866066 with Others was fully satisfied on 02 Jul 2025. was recorded as a recent event.
The activity Asprant Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was completed.
Progress on Suvam Chakraborty was appointed as a Additional Director was appointed as a Additional Director on 29 Nov 2024 & has been associated with this company since 1 year 24 days . was documented.
The activity A charge with Others amounted to Rs. 2.00 M with Charge ID 100866066 was registered on 17 Feb 2024. was completed.
Progress on Raju Talukdar was appointed as a Director was appointed as a Director on 15 Dec 2022 & has been associated with this company since 3 years 9 days . was documented.
The CIN of Asprant Life Science Private Limited is U24299WB2018PTC226270.
Asprant Life Science Private Limited is headquartered at A/53, Purbadiganta,, Kolkata, West Bengal, 700075.
Asprant Life Science Private Limited was incorporated on 24 May 2018.
The current directors of Asprant Life Science Private Limited are
The primary industry of Asprant Life Science Private Limited is Trade.
Asprant Life Science Private Limited is unlisted.
The authorized capital of Asprant Life Science Private Limited is ₹1.00 M, and the paid-up capital is ₹0.16 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX